| Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868) |
|---|
| 09/28/2005 | CN1675179A Fluorinated monomers, fluorinated polymers having polycyclic groups with fused 4-membered heterocyclic rings, useful as photoresists, and processes for microlithography |
| 09/28/2005 | CN1673217A Copolymer of cationic iridium coordination compound and fluorene and its synthesis process |
| 09/27/2005 | US6949263 Method for preparing nicotianamine or nicotianamine-containing product |
| 09/22/2005 | WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 09/22/2005 | US20050209212 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid; carbapenems derivatives containing a carboxy substituted phenyl group; broad spectrum antibacterial activity; good stability; beta-lactamases inhibitors; improvement over imipenem |
| 09/22/2005 | US20050209165 Hypercholesterolemia, cholesterol-associated benign and malignant tumors; hyperlipidemia, arteriosclerosis, and sitosterolemia; 6) (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(2',3',4'-trimethoxybiphenyl-4-yl)azetidin-2-one |
| 09/22/2005 | CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 09/21/2005 | CN1219510C Benzimidazole derivatives as modulators of IgE |
| 09/20/2005 | US6946458 N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus |
| 09/14/2005 | EP1572628A1 Isophtalic acid derivatives |
| 09/13/2005 | CA2279276C Arylsulfonylamino hydroxamic acid derivatives |
| 09/09/2005 | WO2005082841A1 Immunosuppressant compounds and compositions |
| 09/09/2005 | WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof |
| 09/09/2005 | CA2553572A1 Immunosuppressant compounds and compositions |
| 09/08/2005 | US20050197325 Substituted spiro azabicyclics as modulators of chemokine receptor activity |
| 09/07/2005 | CN1665783A Diphenylazetidinone derivatives for treating disorders of the lipid metabolism |
| 09/07/2005 | CN1217927C Novel 1, 2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
| 09/01/2005 | WO2005080376A1 Substituted spiro azabicyclics as modulators of chemokine receptor activity |
| 08/31/2005 | EP1568688A1 Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient |
| 08/31/2005 | CN1662495A Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 08/31/2005 | CN1662494A Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 08/31/2005 | CN1662493A Ring -substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 08/30/2005 | US6936445 Comprises hydrolase for N-benzylazetidine-2-carboxylic acid ester immolbilized on poroous divinylbenzene-styrene copolymer |
| 08/25/2005 | WO2005077899A2 Amino-substituted tricyclic derivatives and methods of use |
| 08/25/2005 | WO2005077897A1 Substituted azetidine compounds, their preparation and use as medicaments |
| 08/25/2005 | WO2005077896A1 Substituted azetidine compounds as cyclooxygenase-1-cyclooxygenase-2 inhibitors, and their preparation and use as medicaments |
| 08/25/2005 | WO2005077463A2 Ligand for a monoamine receptor or transporter for treating addiction or dependence |
| 08/25/2005 | WO2005062824A3 Anti-hypercholesterolemic compounds |
| 08/25/2005 | US20050187392 Hydrolytic kinetic resolution of cyclic substrates |
| 08/25/2005 | US20050187208 Substituted Azetidine compounds, their preparation and use as medicaments |
| 08/25/2005 | CA2556565A1 Substituted azetidine compounds, their preparation and use as medicaments |
| 08/25/2005 | CA2556398A1 Substituted azetidine compounds as cyclooxygenase-1-cyclooxygenase-2 inhibitors, and their preparation and use as medicaments |
| 08/25/2005 | CA2555884A1 Amino-substituted tricyclic derivatives and methods of use |
| 08/24/2005 | CN1658903A Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/23/2005 | CA2253711C Improved process for the production of enantiomerically-pure azetidine-2-carboxylic acid |
| 08/18/2005 | US20050182041 N-Benzoylazetidines, e.g., N-(3,5-di-tert-butyl-4-hydroxybenzoyl)-3-hydroxyazetidine; cyclooxygenase-1 and/or cyclooxygenase-2 inhibitors; treating inflammatory diseases including various kinds of arthritis, lupus, dysmenorrhea, ankylosing spondylitis, edema, migraines, and aplastic anemia |
| 08/17/2005 | EP1562927A2 Thio-analogues of paclitaxel and intermediates thereof |
| 08/17/2005 | EP1562925A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/17/2005 | EP0894085B1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
| 08/17/2005 | CN1656067A New salts |
| 08/17/2005 | CN1656066A Pharmaceutical combination |
| 08/17/2005 | CN1655761A Modified release pharmaceutical formulation |
| 08/17/2005 | CN1655760A Immediate release pharmaceutical formulation |
| 08/16/2005 | US6930189 Chiral ligand |
| 08/11/2005 | US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors |
| 08/10/2005 | EP1561748A1 Malonic acid monoesters and process for producing the same |
| 08/10/2005 | EP1109782B1 PROCESS FOR THE PRODUCTION OF N-PROTECTED AZETIDINE-2-CARBOXYLIC ACIDS (AzeOHs) |
| 08/10/2005 | CN1653025A NK1 antagonists |
| 08/10/2005 | CN1652779A Treatment of chemokine mediated diseases |
| 08/09/2005 | CA2258217C Substituted cyclopentane compounds useful as neuraminidase inhibitors |
| 08/04/2005 | WO2005070877A1 Diamino alcohols and their use as renin inhibitors |
| 08/04/2005 | US20050171083 Modified release pharmaceutical formulation |
| 08/04/2005 | US20050171082 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same |
| 08/04/2005 | US20050171080 Reacting 3-{2-[3-(fluorophenyl)-3-(trimethyl silyloxy)-propyl]-3-(4-fluoro phenyl amino)-3-(4-trimethyl silyloxy phenyl)-1-oxo-propyl}-4-(S)-phenyl oxazolidin-2-one with bis(trimethylsilyl)acetamide, quenching, adding sulfuric acid in an alcohol, isolating form I; pressurization of form I to form II |
| 08/04/2005 | US20050171079 2,7-bis-[(3R)-1-azabicyclo[2.2.2]octan-3-yloxy]-fluoren-9-one; 2,7-bis[(2R)-azetidin-2-ylmethoxy]-fluoren-9-one; alpha 7 Nicotinic acetylcholine receptors ligands; cognitive disorder, neurodegeneration, and neurodevelopmental disorders |
| 08/04/2005 | CA2553831A1 Diamino alcohols and their use as renin inhibitors |
| 08/03/2005 | EP1558253A2 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 08/02/2005 | US6924289 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc. |
| 07/28/2005 | DE10360745A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 07/26/2005 | US6921758 Amino acid derivatives |
| 07/21/2005 | WO2005066120A2 Process for asymmetric synthesis of hydroxy-alkyl substituted azetidinone derivatives |
| 07/21/2005 | US20050159427 N-acylsulfonamide apoptosis promoters |
| 07/20/2005 | EP1268396B1 Diphenyl ether compounds useful in therapy |
| 07/14/2005 | WO2005063704A1 Azetidine ring compounds and drugs comprising the same |
| 07/14/2005 | WO2005063239A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 07/14/2005 | WO2005062897A2 Polymorphs of ezetimibe and processes for the preparation thereof |
| 07/14/2005 | WO2005062824A2 Anti-hypercholesterolemic compounds |
| 07/14/2005 | CA2550649A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 07/13/2005 | EP1551797A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 07/13/2005 | CN1638761A Azetidine derivatives as CCR-3 receptor antagonists |
| 07/13/2005 | CN1210274C Piperazine and piperidine derivatives |
| 07/07/2005 | WO2005061452A1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| 07/07/2005 | WO2005061451A1 Diphenylazetidinone derivates processing cholesterol absorption inhibitory activity |
| 07/07/2005 | WO2005049593A3 N-acylsulfonamide apoptosis promoters |
| 07/07/2005 | WO2005037779A3 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 07/07/2005 | CA2550215A1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| 07/07/2005 | CA2548410A1 Diphenylazetidinone derivates processing cholesterol absorption inhibitory activity |
| 07/06/2005 | CN1209350C Process for synthesizing L-N-protective group-azacyclobutane-2-carboxylic acid |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005020899A3 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 06/30/2005 | WO2004100960A8 Anti-inflammatory phosphonate compounds |
| 06/30/2005 | WO2004096236A3 Immunomodulator phosphonate conjugates |
| 06/30/2005 | US20050143372 Compounds, pharmaceutical compositions and methods of use therefor |
| 06/30/2005 | DE10356489A1 Azetidin-Derivate, Verfahren zu ihrer Hertstellung sowie deren Verwendung Azetidine derivatives, processes for their Hertstellung and their use |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/29/2005 | CN1208342C [2-[5-(2-chloropyridineoxy)]methyl] azacyclobutane polypeptide derivative and its application |
| 06/28/2005 | CA2154071C Process for preparation of taxane derivatives and .beta.-lactam intermediates therefor |
| 06/23/2005 | WO2005056003A1 Dpp-iv inhibitors |
| 06/23/2005 | US20050135737 Optical interleaver |
| 06/23/2005 | CA2548742A1 Dpp-iv inhibitors |
| 06/22/2005 | EP1542968A1 Process for preparing intermediates |
| 06/22/2005 | CN1630629A 酯化合物及其医药用途 Ester compounds and pharmaceutical use |
| 06/21/2005 | US6908996 Compounds and method for preparing 3-methylcephams |
| 06/16/2005 | WO2005054185A1 Azetidine derivatives, method for producing said derivatives and use thereof |
| 06/16/2005 | WO2005054184A1 Process for converting heterocyclic ketones to amido-substituted heterocycles |
| 06/16/2005 | WO2004096286A3 Antiviral phosphonate analogs |
| 06/16/2005 | US20050130953 Pharmacological uses of azetidine derivatives |
| 06/16/2005 | CA2547807A1 Process for converting heterocyclic ketones to amido-substituted heterocycles |
| 06/15/2005 | EP1541175A2 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 06/15/2005 | EP1541143A1 Dpp-iv inhibitors |